Creative Diagnostics Announces the Offering of Native Viral Antigens
Creative Diagnostics recently launches a broad range of native viral antigens for diagnostic laboratories and research institutes.
- (1888PressRelease) January 26, 2022 - As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a broad range of native viral antigens for diagnostic laboratories and research institutes, which are an ideal basis for the development and production of infectious disease kits and reagents. All antigens are purified using a range of techniques to ensure optimal performance in diagnostic applications.
Viruses are infectious pathogens that cause many diseases. They are small particles, usually between 20 and 300 nanometers in length, and contain RNA or DNA. Viruses need host cells to replicate. Pathogens can cause widespread and devastating human disease epidemics. In the past two decades, almost all outbreaks of clinical and public health importance have been caused by newly emerged viruses, including severe acute respiratory syndrome (SARS) coronavirus, Sin Nombre hantavirus, 2009 pandemic influenza H1N and the recently described coronavirus EMC and H7N9 avian influenza viruses. The identification of new pathogens has a huge impact on infectious diseases, microbiology and human health. The currently available viral diagnostic tests are culture, serology, or targeted nucleic acid-based testing.
Natural antigens are extracted in their natural form from appropriate sources. Pathogen-specific natural antigens are known for their high sensitivity in diagnostic applications and are widely used in immunodiagnostic analysis, especially IgM detection. If researchers are considering to develop immunodiagnostic tests, natural antigens are more appropriate.
Creative Diagnostics now offers a series of new native viral antigens for diagnostic laboratories and research institutes, which are an ideal basis for the development and production of infectious disease kits and reagents. All of these new antigens are purified using a range of techniques to ensure optimal performance in diagnostic applications. "Creative Diagnostics is proud to offer the highest quality antigens supported by extensive research, development, and validation. We are committed to the highest standards of product performance, and our scientists are dedicated to accelerating your discoveries." said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.
There are many viruses that can cause diseases, such as Epstein-Barr virus (EBV) that causes infectious mononucleosis, respiratory syncytial virus (RSV) that causes lower respiratory tract infections in young children, influenza viruses such as H1N1 that causes influenza (flu), and human immunodeficiency virus (HIV) that causes AIDS. For these different viruses, Creative Diagnostics has prepared related products to help scientists. For examples, Creative Diagnostics offers Native RSV (Strain Long) for RSV research, Native EBV (Strain P3HR1) Extract Antigen for EBV studies, and native EBV (Strain P3HR1) Extract Antigen for EBV projects.
If you want to know more details about native viral antigens products list or have any other questions about our IVD raw materials, please visit Creative Diagnostics at https://www.creative-diagnostics.com.
About Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers' assay development and manufacturing needs.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam